Drug search by name

Durvalumab Intravenous and Pneumonitis

Result of checking the interaction of drug Durvalumab Intravenous and disease Pneumonitis for safety when used together.

Check result:

Durvalumab Intravenous <> Pneumonitis

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Durvalumab can cause immune-mediated pneumonitis. Monitor patients for signs and symptoms of pneumonitis. Evaluate patients with suspected pneumonitis with radiographic imaging. It is recommended to administer corticosteroids at a dose of 1 to 2 mg/kg/day prednisone equivalents for moderate pneumonitis or 1 to 4 mg per kg per day or equivalent corticosteroid for more severe pneumonitis, followed by a taper. It is recommended to interrupt or permanently discontinue durvalumab based on the severity of symptoms. Care should be exercised when using this agent in patients with suspected pneumonitis.

Durvalumab Intravenous

Generic Name: durvalumab

Brand Name: Imfinzi

Synonyms: Durvalumab

What is Durvalumab Intravenous?